InsiderDB

Charles River Laboratories International (CRL)

Healthcare · Medical - Diagnostics & Research

5 members of Congress have disclosed 9 trades in Charles River Laboratories International (CRL) since 2023: 6 buys and 3 sales. The most recent was disclosed on Jun 22, 2025.

Trades disclosed
9
Members trading
5
Buys / sells
6 / 3
Reported value
$51K–$240K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow CRL

What else is happening at CRL

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. CRLLobbying report·Lobbying disclosures

    CRL: third_quarter 2026 lobbying report

    Issues surrounding improvements to clinical research capabilities and modernization of research methods. Issues related to preclinical testing safety assessments, including New Approach Methodologies and virtual control groups Issues surrounding improvements to clinical research capabilities and modernization of research methods. Issues surrounding improvements to clinical research capabilities and modernization of research methods.

    Public: Oct 20, 2026, 9:28 PM EDTOriginal source ↗
  2. CRLLobbying report·Lobbying disclosures

    CRL: second_quarter 2026 lobbying report

    Issues surrounding improvements to clinical research capabilities and modernization of research methods. Issues related to preclinical testing safety assessments, including New Approach Methodologies and virtual control groups Issues surrounding improvements to clinical research capabilities and modernization of research methods. Issues surrounding improvements to clinical research capabilities and modernization of research methods.

    Public: Jul 20, 2026, 10:36 PM EDTOriginal source ↗

Who traded CRL

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.